Labshake search
Citations for Stemcell Technologies :
1 - 50 of 662 citations for 2 Triisopropylsilyl Oxazole 5 Carbaldehyde since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... 2 µM (for iPSC) or 5 µM (for ESC) XAV939 (Stemcell Technologies), and 10 µM Y27632 ...
-
bioRxiv - Cell Biology 2024Quote: ... 5% CO2 for 2 weeks in supplemented mTeSR medium (STEMCELL Technologies #85850). For KO of C3orf58 or SLC39A9 in iPSC ...
-
bioRxiv - Developmental Biology 2022Quote: ... 5 ng/mL FGF-2 (RnD Systems) and 1 µM CHIR99021 (Stem Cell Technologies) with daily medium exchange for 3 days ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 ng/ml FGF-2 (RnD Systems) and 1 μM CHIR99021 (Stem Cell Technologies). Mesoderm induction required daily medium exchanges for 3 days ...
-
bioRxiv - Cell Biology 2023Quote: ... 5 ng/ml FGF-2 (RnD Systems) and 1 μM CHIR99021 (Stemgent or Stem Cell Technologies). Mesoderm induction required daily medium exchanges for 3 days ...
-
bioRxiv - Cancer Biology 2023Quote: ... for 5-7 days and embedded into 2 mg/ml collagen type-I (StemCell Technologies, Vancouver, Canada) gels ...
-
bioRxiv - Bioengineering 2021Quote: ... at 5×105 LSK/mL and cultured for 2 h at 5% CO2 and 37 °C in 500 µL SFEM media (#09650, Stemcell Technologies) supplemented with 100 ng/mL SCF (#250-03 ...
-
bioRxiv - Cell Biology 2022Quote: ... then gently detached with Accutase and reseeded as 2-5×104 cells/cm2 in mTeSR medium containing 10uM Y-27632 (#72304, STEMCELL Technologies) ROCK inhibitor (removed after 48h and exchanged for fresh medium without ROCK inhibitor) ...
-
bioRxiv - Physiology 2022Quote: ... Proteases were neutralized with medium containing 10% FBS and resulting suspension of cells were incubated in a flask at 37°C 5% CO2 for 2 hours in PneumaCult-Ex Plus medium (Cat. 05040, Stemcell Technologies) with 100 U/mL penicillin and 100 μg/mL streptomycin to remove non-epithelial cells ...
-
bioRxiv - Immunology 2023Quote: ... For 5-azacytidine (5-aza; Stem Cell Technologies) and trehalose 6,6’-dimycolate (TDM ...
-
bioRxiv - Bioengineering 2021Quote: hiPSC-derived endothelial cells (hECs) were differentiated as previously described.[85] hiPSCs were subjected to 5 μM CHIR99021 in STEMdiff APEL 2 Medium (STEMCELL Technologies, 05270) for 24 hours ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were treated with cardiomyocytes differentiation basic medium (2 mM L-glutamine RPMI-1640 plus 1x B27 minus insulin) containing 5 μM CHIR99021 (STEMCELL Technologies, Canada) for 48 hours ...
-
bioRxiv - Biophysics 2024Quote: ... Labeled ASCs were suspended in 2 mL PBS and incubated for 5 minutes in an EasySep™ magnet (Stemcell Technologies, Vancouver, CAN) to separate the iron-labeled cells from the unlabeled.
-
bioRxiv - Cell Biology 2021Quote: ... 5 × 105 cells were pelleted at 350x g for 2 min and transferred onto a 6-well transwell membrane (Stem Cell Technologies, #3450). Pellets were incubated with CHIR99021 (5 µM ...
-
bioRxiv - Bioengineering 2021Quote: ... T cells were frozen at 1-2 × 107 cells/mL and NK cells were frozen at 5 × 106 cells/mL in CryoStor CS10 (STEMCELL Technologies, Cambridge, MA) and thawed into culture as needed ...
-
bioRxiv - Genomics 2024Quote: ... hESCs were fed every day for mTeSR1 or every 2 days for mTeSR Plus and passaged every 5–6 days using ReLeSR (Stem Cell Technologies 05872).
-
bioRxiv - Microbiology 2023Quote: ... 2 µl of 2% rat serum (Stemcell technologies) was added to each well for 15 minutes at room temperature and proceeded to further staining without a washing step.
-
bioRxiv - Microbiology 2024Quote: ... 5 µM CHIR99021 (StemCell technologies) and 1.25% V/V DMSO) ...
-
Arc mediates intercellular synaptic plasticity via IRSp53-dependent extracellular vesicle biogenesisbioRxiv - Neuroscience 2024Quote: ... 2% SM1 (StemCell Technologies), 500 µM L-Glutamine ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5% CO2 and 5% O2 in in growth media comprised of StemSpan SFEM II (STEMCELL Technologies) base media supplemented with 20 ng/mL of TPO ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5% CO2 and 5% O2 in AML pre-culture media comprised of MyeloCult H5100 (STEMCELL Technologies) base media supplemented with 20 ng/mL each of TPO ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 µM Dorsomorphin (StemCell Technologies, 72102), 10 µM SB431542 (StemCell Technologies ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 5% FBS (StemCell Technology), L-glutamine (2 mM) ...
-
bioRxiv - Pathology 2022Quote: ... and 5 µM SB431542 (StemCell Technologies). On Days8-14 ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 unit/ml Dispase (Stemcell Technologies) and 0.05 mg/ml DNase I (Roche)) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 mg/mL dispase (STEMCELL Technologies), supplemented with 100 µg/mL DNase1 (Sigma-Aldrich) ...
-
bioRxiv - Bioengineering 2023Quote: ... 5 µM Y27632 (72034; STEMCELL Technologies), 500 nM SB-202190 (S7067 ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... 5 µM A83-01 (STEMCELL Technologies) and 10 µM forskolin (Sigma-Aldrich) ...
-
bioRxiv - Developmental Biology 2021Quote: ... Definitive endoderm cells are then differentiated into anterior ventral foregut endoderm (Stage 2) using dual SMAD inhibition for 2 days with 2 µM Dorsomorphin (STEMCELL Technologies, cat#72102) and 10 µM SB431542 (STEMCELL Technologies ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Neuroscience 2021Quote: ... 2 µM XAV939 (STEMCELL Technologies), 10 µM SB431542 hydrate and 2 µg/mL doxycycline hyclate (Sigma) ...
-
bioRxiv - Pathology 2022Quote: ... 2 µM CHIR99021 (StemCell Technologies), and 10 ng/mL Recombinant Human BMP-7(Peprotech) ...
-
bioRxiv - Cell Biology 2022Quote: ... 2% SM1 (Stem Cell Technologies), 15mM HEPES (Gibco) ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% SM1 (05711, STEMCell Technologies), 1% N2 (07152 ...
-
bioRxiv - Neuroscience 2023Quote: ... IWP-2 (STEMCELL Technologies, 72124), RA (Sigma ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Neuroscience 2024Quote: ... DMH1 (STEMCELL Technologies; 2 µM), and XAV939 (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2% SM1 (StemCell Technologies). The cells were then plated on coverslips (Carolina ...
-
bioRxiv - Developmental Biology 2024Quote: ... 2 µM SB431542 (StemCell Technologies), 1 µM DMH1 (Tocris Bioscience) ...
-
bioRxiv - Neuroscience 2024Quote: ... 2 µM Cyclopamine (StemCell Technologies), 2 µg/mL Heparin ...
-
bioRxiv - Neuroscience 2024Quote: ... 2 μM DMH1 (StemCell Technologies), and 2 μM SB431542 (Stemgent ...
-
bioRxiv - Cell Biology 2021Quote: ... for 5 min followed by a 3 min treatment with 5 mg/mL dispase (Stem Cell Technologies, 07913) and 1 mg/mL DNase I (Sigma ...
-
Pluripotent stem cell SOX9 and INS reporters facilitate differentiation into insulin-producing cellsbioRxiv - Developmental Biology 2021Quote: ... 5 ng/ml FGF7 (Stem Cell Technologies), 2 µM IWR-1 (Selleck Chemicals ...
-
bioRxiv - Cell Biology 2021Quote: ... suplemented with 5% FBS (StemCell Technology, 06200) and the same reagents and cytokine cocktail than the methylcellulose assays (full cytokine medium) ...
-
bioRxiv - Microbiology 2022Quote: ... 5 μM Y-27632 (Stem Cell Technologies), 1 μM A-83-01 (Tocris) ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 mM L-Glutamine (Stemcell Technologies; 07100), and 35 μg/ml L-Glutamic Acid (Sigma Aldrich ...
-
bioRxiv - Neuroscience 2022Quote: ... supplemented with mTeSR1 5× Supplement (StemCell Technologies), ensuring the colony sizes were around 50-100 μm in diameter ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5 μM SB-431542 (StemCell Technologies, 72234), and 1 μM LDN-193189 (StemCell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 mM L-glutamine (STEMCELL Technologies, 07100), and 35 μg ml-1 of L-glutamic acid (Sigma-Aldrich ...